DDDCX
Price
$18.35
Change
+$0.03 (+0.16%)
Updated
Jul 14 closing price
Net Assets
115.02M
FSMAX
Price
$95.11
Change
+$0.76 (+0.81%)
Updated
Jul 14 closing price
Net Assets
39.17B
Interact to see
Advertisement

DDDCX vs FSMAX

Header iconDDDCX vs FSMAX Comparison
Open Charts DDDCX vs FSMAXBanner chart's image
13D Activist C
Price$18.35
Change+$0.03 (+0.16%)
VolumeN/A
Net Assets115.02M
Fidelity Extended Market Index
Price$95.11
Change+$0.76 (+0.81%)
VolumeN/A
Net Assets39.17B
DDDCX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDDCX vs. FSMAX commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDCX is a Buy and FSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.2B vs. DDDCX (115M). FSMAX pays higher dividends than DDDCX: FSMAX (0.47) vs DDDCX (0.00). DDDCX was incepted earlier than FSMAX: DDDCX (13 years) vs FSMAX (14 years). DDDCX (2.51) is less costly to investors than FSMAX (0.04). DDDCX is a more actively managed with annual turnover of: 104.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than DDDCX: FSMAX (0) vs DDDCX (2500). FSMAX annual gain was more profitable for investors over the last year : 13.49 vs. DDDCX (-6.39). FSMAX return over 5 years is better than : 57.69 vs. DDDCX (-7.84).
DDDCXFSMAXDDDCX / FSMAX
Total Expense Ratio2.510.047,171%
Annual Report Gross Expense Ratio2.510.047,171%
Fund Existence13 years14 years-
Gain YTD-3.8823.818-102%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets115M39.2B0%
Annual Yield % from dividends0.000.47-
Returns for 1 year-6.3913.49-47%
Returns for 3 years-16.9552.36-32%
Returns for 5 years-7.8457.69-14%
Returns for 10 years4.6577.516%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRTS4.320.16
+3.85%
Sensus Healthcare
CLOV3.000.08
+2.74%
Clover Health Investments Corp
TARS41.530.37
+0.90%
Tarsus Pharmaceuticals
BWA35.670.26
+0.73%
BorgWarner
OXLCP24.520.09
+0.35%
Oxford Lane Capital Corp